| Issue Date | Title | Author(s) |
| 2015-04-01 | Microparticles in cancer: A review of recent developments and the potential for clinical application | Gong, J; Jaiswal, R; Dalla, P; Luk, F; Bebawy, M |
| 2013-01-01 | Glioma microvesicles carry selectively packaged coding and noncoding RNAs which alter gene expression in recipient cells | Li, CCY; Eaton, SA; Young, PE; Lee, M; Shuttleworth, R; Humphreys, DT; Grau, GE; Combes, V; Bebawy, M; Gong, J; Brammah, S; Buckland, ME; Suter, CM |
| 2018-12-01 | Assessing the potential of liposomes loaded with curcumin as a therapeutic intervention in asthma | Ng, ZY; Wong, JY; Panneerselvam, J; Madheswaran, T; Kumar, P; Pillay, V; Hsu, A; Hansbro, N; Bebawy, M; Wark, P; Hansbro, P; Dua, K; Chellappan, DK |
| 2012-03-01 | Modification of disodium cromoglycate passage across lung epithelium in vitro via incorporation into polymeric microparticles | Haghi, M; Salama, R; Traini, D; Bebawy, M; Young, PM |
| 2018-01 | Nanoparticles in Cancer Treatment: Opportunities and Obstacles. | Awasthi, R; Roseblade, A; Hansbro, PM; Rathbone, MJ; Dua, K; Bebawy, M |
| 2018-03-01 | Tumor suppressor role of miR-503 | Gupta, G; Chellappan, DK; De Jesus Andreoli Pinto, T; Hansbro, PM; Bebawy, M; Dua, K |
| 2012-01-01 | Microparticles and their emerging role in cancer multidrug resistance | Gong, J; Jaiswal, R; Mathys, JM; Combes, V; Grau, GER; Bebawy, M |
| 2014-01-01 | In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation | Ong, HX; Benaouda, F; Traini, D; Cipolla, D; Gonda, I; Bebawy, M; Forbes, B; Young, PM |
| 2018-08-01 | Functional relevance of SATB1 in immune regulation and tumorigenesis | Sunkara, KP; Gupta, G; Hansbro, PM; Dua, K; Bebawy, M |
| 2012-01 | Inhaled Liposomal Ciprofloxacin Nanoparticles Control the Release of Antibiotic at the Bronchial Epithelia | Ong, HX; Cipolla, DC; Gonda, I; Traini, D; Bebawy, M; Agus, H; Young, PM; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM |
